Arrowhead Pharmaceuticals
ARWR
#1838
Rank
NZ$20.09 B
Marketcap
NZ$142.63
Share price
0.96%
Change (1 day)
447.94%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): NZ$0.62 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are NZ$1.09 Billion. , an increase over its 2024 earnings that were of -NZ$1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.60 B-157.5%
2024 -NZ$1.05 Billion112.45%
2023 -NZ$0.5 Billion87.79%
2022 -NZ$0.27 Billion-20.1%
2021 -NZ$0.33 Billion67.59%
2020 -NZ$0.2 Billion-347.53%
2019 NZ$79.12 M-245.59%
2018 -NZ$54.35 Million-13.17%
2017 -NZ$62.6 Million-52.28%
2016 -NZ$0.14 Billion-16.57%
2015 -NZ$0.16 Billion30.32%
2014 -NZ$0.13 Billion171.62%
2013 -NZ$44.42 Million16.56%
2012 -NZ$38.11 Million107.53%
2011 -NZ$18.37 Million
2008 -NZ$64.69 Million-8.07%
2007 -NZ$70.36 Million70.37%
2006 -NZ$41.3 Million122.51%
2005 -NZ$18.56 Million147.41%
2004 -NZ$7.51 Million2002.28%
2003 -NZ$0.36 Million-85.61%
2002 -NZ$2.49 Million1371.97%
2001 -NZ$0.17 Million-13.45%
2000 -NZ$0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.28 B 7,427.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.43 Billion-1,001.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.28 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.51 B 151.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-NZ$0.19 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA